LeMaitre VascularLMAT +1.84%97 EV-to-FCF is 25.36 as of Jun. 28, 2026, which is 36% below its 10-year median of 39.76. GuruFocus rates LMAT with a GF Score™ of 97/100 and a GF Value™ of $96.94 (Fairly Valued). The stock has 1 warning sign investors should review. Among 421 Medical Devices & Instruments companies, LeMaitre Vascular ranks worse than 54.63% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, LeMaitre Vascular's Enterprise Value is $2,006.2 Mil.
LeMaitre Vascular's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $79.1 Mil. Therefore, LeMaitre Vascular's EV-to-FCF for today is 25.36.
The historical rank and industry rank for LeMaitre Vascular's EV-to-FCF or its related term are showing as below:
LMAT'
s EV-to-FCF Range Over the Past 10 Years
Min: 19.67 Med: 39.76 Max: 80.27
Current: 25.36
During the past 13 years, the highest EV-to-FCF of LeMaitre Vascular was 80.27. The lowest was 19.67. And the median was 39.76.
LMAT's EV-to-FCF is ranked worse than 54.63% of 421
companies
in the Medical Devices & Instruments industry
Industry Median: 22.82
vs LMAT: 25.36
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
LeMaitre Vascular's PE Ratio (TTM) for today is calculated as:
LeMaitre Vascular's share price for today is $95.56.
LeMaitre Vascular's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.710.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
LeMaitre Vascular EV-to-FCF Related Terms
LeMaitre Vascular EV-to-FCF Historical Data
* Premium members only.
The historical data trend for LeMaitre Vascular's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's EV-to-FCF falls into.
LeMaitre Vascular's current Enterprise Value is $2,006.2 Mil.
LeMaitre Vascular's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $79.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (LMAT) has a EV-to-FCF of 25.36 as of Jun. 28, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on LeMaitre Vascular and its competitors. This is 36% below median its historical median of 39.76. Over the past decade, LeMaitre Vascular's EV-to-FCF has ranged from 19.67 to 80.27. According to the industry distribution chart, LeMaitre Vascular ranks #230 out of 421 companies in the Medical Devices & Instruments industry, placing it in the top 54.6%.
Is LeMaitre Vascular's EV-to-FCF too high?
LeMaitre Vascular's current EV-to-FCF of 25.36 is 36% below median its 10-year median of 39.76. Over the past 10 years, this metric has ranged from a low of 19.67 to a high of 80.27. The Medical Devices & Instruments industry median EV-to-FCF is 22.82. LeMaitre Vascular's value of 25.36 is 11.1% above this industry median. Based on the distribution chart, LeMaitre Vascular ranks #230 out of 421 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, LeMaitre Vascular has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's EV-to-FCF compare to XRAY and PLSE?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #230 out of 421 companies for EV-to-FCF. This places LeMaitre Vascular in the lower half of its industry. The industry median EV-to-FCF is 22.82. LeMaitre Vascular's value of 25.36 is 11.1% above this benchmark. Historically, LeMaitre Vascular's own EV-to-FCF has ranged from 19.67 to 80.27 over the past decade. While the company's 10-year median is 39.76 vs. the industry median of 22.82, LeMaitre Vascular has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.82, based on 421 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current EV-to-FCF of 25.36 is 11.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on LeMaitre Vascular and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current EV-to-FCF is 25.36, which is 36% below median its own 10-year median of 39.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (LMAT) is currently considered Fairly Valued. The stock's GF Value™ is $96.94, compared to a current price of $95.56 — trading 1.4% below its estimated fair value. The current EV-to-FCF is 25.36, which is 36% below median its 10-year median of 39.76 and 11.1% above the Medical Devices & Instruments industry median of 22.82. LeMaitre Vascular's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For LeMaitre Vascular (LMAT), the current EV-to-FCF is 25.36 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (LMAT) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of $95.56 is trading 1.4% below its estimated GF Value™ of $96.94.
GuruFocus considers LeMaitre Vascular to be Fairly Valued.
Key valuation signals for LMAT:
EV-to-FCF: 25.36 (36% below median its 10-year median of 39.76)
GF Value™: $96.94 vs. price of $95.56 (1.4% below fair value)
Industry Position: 11.1% above the Medical Devices & Instruments median (#230 of 421)
No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
97GF Score
Get the complete analysis for LMAT
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMAT has been successfully added to your 
